Rochester, MN–(ENEWSPF)–March 1, 2012. Federal officials should reclassify cannabis under federal law and permit “long-stifled research into a potential trove of (the plant’s) therapeutic applications,” according to review published in the February issue of the journal Mayo Clinic Proceedings, a peer-reviewed journal sponsored by Mayo Clinic in Rochester, Minnesota.
The review, entitled “Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana,” states: “Bureaucratic hurdles not erected for other potential pharmaceuticals continue to interfere with legitimate cannabis research. The federal government instituted its 1970 ban in the absence of scientific evidence supporting its position. It maintains the ban, despite scientific evidence suggesting that cannabis could have positive effects on the many organ systems endocannabinoid activity modulates.”
Read complete article here: